• Study Claims COVID Caused More Heart Damage Than Vaccines — Here’s What the Authors Got Wrong

    Rainer Johannes Klement, Ph.D + Harald Walach reanalyzed data and found that while coronaviruses might cause myocarditis, the COVID-19 vaccines cause at least as much or more.

    Study Claims COVID Caused More Heart Damage Than Vaccines — Here’s What the Authors Got Wrong
    A 2023 study admitted that the COVID-19 mRNA vaccines cause myocarditis, but claimed the COVID-19 virus was even more damaging than the vaccine. A recent, more detailed review of their data, however, showed the opposite is likely true.

    Angelo DePalma, Ph.D.
    human heart with covid vaccine
    Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.

    Despite the known side effects of mRNA COVID-19 vaccines, some studies (here, here and here) and health websites (here, here and here) argue that whatever vaccination’s adverse outcomes, being unvaccinated is worse.

    In one such study, Dr. Christian Mueller and his co-authors concluded the COVID-19 virus — not the vaccine — was responsible for more myocarditis, or heart muscle damage, than the vaccine.

    However, when Rainer Johannes Klement, Ph.D., a physicist at Leopoldina Hospital in Schweinfurt, Germany, and Harald Walach, a clinical psychologist and head of the Change Health Institute in Basel, Switzerland, reanalyzed Mueller’s data they found that while coronaviruses might cause myocarditis, the COVID-19 vaccines cause at least as much or more.

    The Klement paper appeared in the Feb. 1 edition of The Egyptian Health Journal.

    Mueller’s study

    Mueller set out to quantify and compare myocarditis in vaxed versus unvaxed subjects and to explain possible mechanisms.

    To explore these mechanisms, the researchers tested subjects for antibodies against interleukin-1 receptor antagonist (IL-1RA), the SARS-CoV-2-nucleoprotein, the viral spike protein and 14 inflammatory cytokines.

    Since none of these measures differed between study groups, the “mechanism” issue was unresolved.

    To assess myocarditis investigators tested 777 hospital workers (median age 37, 69.5% women) for cardiac troponin T one and three days after they received an mRNA-1273 booster. Cardiologists typically prescribe this test after a suspected heart attack to quantify the extent and duration of heart damage.

    Of the 40 subjects (5.1%) with elevated troponin on Day 3, 22 (2.8%) were diagnosed with myocarditis, with 20 cases occurring in women and two in men.

    The researchers reported that among these subjects troponin elevations were mild and temporary and did not involve abnormalities as determined by electrocardiogram. No patients experienced “major adverse cardiac events” within 30 days of receiving the shot.

    Mueller’s team concluded:

    COVID-19 associates with a substantially higher risk for myocarditis that [sic] mRNA vaccination …
    Myocarditis related to COVID-19 infection has shown a higher mortality than myocarditis related to mRNA vaccination.
    Before the COVID-19 vaccine were [sic] available, the incidence and extent of myocardial injury associated with COVID-19 infection was [sic] much higher than observed in this active surveillance study after booster vaccination.
    One of the Mueller co-authors had commercial ties to diagnostics companies. Another had previously been compensated by diagnostics and vaccine manufacturers. Mueller had relationships with diagnostics, pharmaceutical and vaccine companies at the time he wrote the paper.

    Where did Mueller go wrong?

    One way to measure treatment effects is to compare an outcome, for example, blood pressure, in the same subjects before and after the treatment and report before-and-after results.

    Although this option was known to medical researchers and available to him, Mueller did not take advantage of it — either because he did not think to measure pre-booster troponin levels or chose not to report them for some reason, perhaps because they did not align with his other results.

    Instead, his team took an approach that required two well-matched study groups. Although Mueller claimed placebos and controls met this requirement they differed on the feature that mattered most: heart health.

    Vaccinated subjects with current or recent heart issues were excluded from the study, while all control subjects had just entered the hospital with heart symptoms and were therefore already at greater risk for myocarditis.

    Klement and Walach found more anomalies in the Mueller paper.

    RFK Jr. and Brian Hooker Vax-Unvax
    RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax”

    Order Now

    They began their critique by citing three 2021 studies on COVID-19 vaccine-induced myocarditis (here, here and here). All three studies showed myocarditis became a concern shortly after the COVID-19 vaccine introductions.

    They discussed three papers in some detail:

    A 2023 German autopsy study on 25 unexpected deaths within 20 days of COVID-19 vaccination identified acute myocarditis as the most probable cause of death in four cases.
    A 2023 report on myocarditis in 303 non-vaccinated and 700 vaccinated asymptomatic subjects found significantly higher damage in the vaccinated persisting for up to 180 days post-vaccination.
    One of the first autopsy papers, an Indian-led study based on World Health Organization pharmacovigilance data reported 2.1 times the risk for cardiac arrest, 2.7 times the risk for acute heart attack, 2.6 times the risk for elevated troponin, and 7.3-fold higher levels of D-dimer for COVID-19 vaccinations compared with the use of other medications.
    These studies strongly suggest that myocarditis became an issue only after the mRNA vaccine rollouts. They contradict Mueller’s statement that the “extent of myocardial injury associated with COVID-19 infection was much higher than observed in this active surveillance study after booster vaccination.”

    According to Klement and Walach, this statement is wrong for two reasons.

    First, in addition to the non-equivalence of controls’ and subjects’ heart-health status, Mueller ignored the much larger number of COVID-19-infected, unhospitalized, unvaccinated individuals with (presumably) much lower troponin levels compared with patients entering the hospital with heart symptoms.

    Second, Klement and Walach argued that the public health impact of myocarditis depends not only on the incidence or rate among study groups but the size of those groups. The significance is that a lower incidence in a very large group (vaccinated) is more meaningful than a slightly higher rate in a very small group (individuals infected with COVID-19).

    scales of justice
    Your support helps fund this work, and CHD’s related advocacy, education and scientific research.

    Donate Now

    On that basis, Klement and Walach estimated the number of myocarditis cases among all German COVID-19 hospitalizations at 27,467, and among those who were vaccinated at 1.97 million.

    As a result, regardless of myocarditis severity, there were 71.7 times as many myocarditis cases among the vaccinated as among those hospitalized for COVID-19.

    A similar analysis for Switzerland estimated 169,960 cases of myocarditis among vaccinated compared with 8,179 among those hospitalized for COVID-19. Although not as dramatic as the German estimates this still shows a much higher occurrence of heart damage among vaccinated versus hospitalized.

    In a June 2021 paper, Walach, Klement and Dutch data analyst Wouter Aukema concluded that based on 700 adverse reactions, 16 serious side effects and 4.11 deaths for every 100,000 vaccinations, COVID-19 vaccines were released with insufficient safety data.

    The authors said the risk-benefit ratio for mRNA vaccines did not add up because “for three deaths prevented by vaccination we have to accept two inflicted by vaccination.”

    Mueller told The Defender via email:

    “Our study reveals an important lack of prospective safety data concerning COVID-19 vaccines. Given the magnitude of the vaccinated population compared to the much smaller proportion of the population that became infected and developed symptoms, including a small percentage with possible heart damage, our findings should remain qualitatively robust.”

    LEARN MORE
    https://childrenshealthdefense.org/defender/covid-study-myocarditis-vaccines/

    Join @ShankaraChetty
    🚨 Study Claims COVID Caused More Heart Damage Than Vaccines — Here’s What the Authors Got Wrong Rainer Johannes Klement, Ph.D + Harald Walach reanalyzed data and found that while coronaviruses might cause myocarditis, the COVID-19 vaccines cause at least as much or more. Study Claims COVID Caused More Heart Damage Than Vaccines — Here’s What the Authors Got Wrong A 2023 study admitted that the COVID-19 mRNA vaccines cause myocarditis, but claimed the COVID-19 virus was even more damaging than the vaccine. A recent, more detailed review of their data, however, showed the opposite is likely true. Angelo DePalma, Ph.D. human heart with covid vaccine Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free. Despite the known side effects of mRNA COVID-19 vaccines, some studies (here, here and here) and health websites (here, here and here) argue that whatever vaccination’s adverse outcomes, being unvaccinated is worse. In one such study, Dr. Christian Mueller and his co-authors concluded the COVID-19 virus — not the vaccine — was responsible for more myocarditis, or heart muscle damage, than the vaccine. However, when Rainer Johannes Klement, Ph.D., a physicist at Leopoldina Hospital in Schweinfurt, Germany, and Harald Walach, a clinical psychologist and head of the Change Health Institute in Basel, Switzerland, reanalyzed Mueller’s data they found that while coronaviruses might cause myocarditis, the COVID-19 vaccines cause at least as much or more. The Klement paper appeared in the Feb. 1 edition of The Egyptian Health Journal. Mueller’s study Mueller set out to quantify and compare myocarditis in vaxed versus unvaxed subjects and to explain possible mechanisms. To explore these mechanisms, the researchers tested subjects for antibodies against interleukin-1 receptor antagonist (IL-1RA), the SARS-CoV-2-nucleoprotein, the viral spike protein and 14 inflammatory cytokines. Since none of these measures differed between study groups, the “mechanism” issue was unresolved. To assess myocarditis investigators tested 777 hospital workers (median age 37, 69.5% women) for cardiac troponin T one and three days after they received an mRNA-1273 booster. Cardiologists typically prescribe this test after a suspected heart attack to quantify the extent and duration of heart damage. Of the 40 subjects (5.1%) with elevated troponin on Day 3, 22 (2.8%) were diagnosed with myocarditis, with 20 cases occurring in women and two in men. The researchers reported that among these subjects troponin elevations were mild and temporary and did not involve abnormalities as determined by electrocardiogram. No patients experienced “major adverse cardiac events” within 30 days of receiving the shot. Mueller’s team concluded: COVID-19 associates with a substantially higher risk for myocarditis that [sic] mRNA vaccination … Myocarditis related to COVID-19 infection has shown a higher mortality than myocarditis related to mRNA vaccination. Before the COVID-19 vaccine were [sic] available, the incidence and extent of myocardial injury associated with COVID-19 infection was [sic] much higher than observed in this active surveillance study after booster vaccination. One of the Mueller co-authors had commercial ties to diagnostics companies. Another had previously been compensated by diagnostics and vaccine manufacturers. Mueller had relationships with diagnostics, pharmaceutical and vaccine companies at the time he wrote the paper. Where did Mueller go wrong? One way to measure treatment effects is to compare an outcome, for example, blood pressure, in the same subjects before and after the treatment and report before-and-after results. Although this option was known to medical researchers and available to him, Mueller did not take advantage of it — either because he did not think to measure pre-booster troponin levels or chose not to report them for some reason, perhaps because they did not align with his other results. Instead, his team took an approach that required two well-matched study groups. Although Mueller claimed placebos and controls met this requirement they differed on the feature that mattered most: heart health. Vaccinated subjects with current or recent heart issues were excluded from the study, while all control subjects had just entered the hospital with heart symptoms and were therefore already at greater risk for myocarditis. Klement and Walach found more anomalies in the Mueller paper. RFK Jr. and Brian Hooker Vax-Unvax RFK Jr. and Brian Hooker’s New Book: “Vax-Unvax” Order Now They began their critique by citing three 2021 studies on COVID-19 vaccine-induced myocarditis (here, here and here). All three studies showed myocarditis became a concern shortly after the COVID-19 vaccine introductions. They discussed three papers in some detail: A 2023 German autopsy study on 25 unexpected deaths within 20 days of COVID-19 vaccination identified acute myocarditis as the most probable cause of death in four cases. A 2023 report on myocarditis in 303 non-vaccinated and 700 vaccinated asymptomatic subjects found significantly higher damage in the vaccinated persisting for up to 180 days post-vaccination. One of the first autopsy papers, an Indian-led study based on World Health Organization pharmacovigilance data reported 2.1 times the risk for cardiac arrest, 2.7 times the risk for acute heart attack, 2.6 times the risk for elevated troponin, and 7.3-fold higher levels of D-dimer for COVID-19 vaccinations compared with the use of other medications. These studies strongly suggest that myocarditis became an issue only after the mRNA vaccine rollouts. They contradict Mueller’s statement that the “extent of myocardial injury associated with COVID-19 infection was much higher than observed in this active surveillance study after booster vaccination.” According to Klement and Walach, this statement is wrong for two reasons. First, in addition to the non-equivalence of controls’ and subjects’ heart-health status, Mueller ignored the much larger number of COVID-19-infected, unhospitalized, unvaccinated individuals with (presumably) much lower troponin levels compared with patients entering the hospital with heart symptoms. Second, Klement and Walach argued that the public health impact of myocarditis depends not only on the incidence or rate among study groups but the size of those groups. The significance is that a lower incidence in a very large group (vaccinated) is more meaningful than a slightly higher rate in a very small group (individuals infected with COVID-19). scales of justice Your support helps fund this work, and CHD’s related advocacy, education and scientific research. Donate Now On that basis, Klement and Walach estimated the number of myocarditis cases among all German COVID-19 hospitalizations at 27,467, and among those who were vaccinated at 1.97 million. As a result, regardless of myocarditis severity, there were 71.7 times as many myocarditis cases among the vaccinated as among those hospitalized for COVID-19. A similar analysis for Switzerland estimated 169,960 cases of myocarditis among vaccinated compared with 8,179 among those hospitalized for COVID-19. Although not as dramatic as the German estimates this still shows a much higher occurrence of heart damage among vaccinated versus hospitalized. In a June 2021 paper, Walach, Klement and Dutch data analyst Wouter Aukema concluded that based on 700 adverse reactions, 16 serious side effects and 4.11 deaths for every 100,000 vaccinations, COVID-19 vaccines were released with insufficient safety data. The authors said the risk-benefit ratio for mRNA vaccines did not add up because “for three deaths prevented by vaccination we have to accept two inflicted by vaccination.” Mueller told The Defender via email: “Our study reveals an important lack of prospective safety data concerning COVID-19 vaccines. Given the magnitude of the vaccinated population compared to the much smaller proportion of the population that became infected and developed symptoms, including a small percentage with possible heart damage, our findings should remain qualitatively robust.” LEARN MORE ⬇️ https://childrenshealthdefense.org/defender/covid-study-myocarditis-vaccines/ Join ➡️ @ShankaraChetty
    CHILDRENSHEALTHDEFENSE.ORG
    Study Claims COVID Caused More Heart Damage Than Vaccines — Here’s What the Authors Got Wrong
    A 2023 study admitted that the COVID-19 mRNA vaccines cause myocarditis, but claimed the COVID-19 virus was even more damaging than the vaccine. A recent, more detailed review of their data, however, showed the opposite is likely true.
    Like
    1
    0 Comments 0 Shares 14897 Views
  • This one just keeps getting better.
    ElvishMagic that i bought in presale.
    This is their latest announcement ????

    Dear ElvishMagic Fam;
    On 8-9 MAY, CRYPTO306 Dubai, an important and monumental event,take place!

    As ELVISHMAGIC & amagroups , we take our place in the CRYPTO306 Dubai organization on May 8-9, 2023.

    Among the highlights of the meeting for us, there will be the introductions of Metaverse Launchpad and Vr NFT Marketplace, which will be held for the first time in the world in the field of cryptocurrency. We planned talk about on this day to provide an overview of the upcoming powerful changes to the ecosystem! We can show some images and tests that we will present to the community for the first time will be introduced to the world.

    Is this a gem for the next bull run, i hope so.. ????????
    This one just keeps getting better. ElvishMagic that i bought in presale. This is their latest announcement ???? Dear ElvishMagic Fam; On 8-9 MAY, CRYPTO306 Dubai, an important and monumental event,take place! As ELVISHMAGIC & amagroups , we take our place in the CRYPTO306 Dubai organization on May 8-9, 2023. Among the highlights of the meeting for us, there will be the introductions of Metaverse Launchpad and Vr NFT Marketplace, which will be held for the first time in the world in the field of cryptocurrency. We planned talk about on this day to provide an overview of the upcoming powerful changes to the ecosystem! We can show some images and tests that we will present to the community for the first time will be introduced to the world. Is this a gem for the next bull run, i hope so.. ????????
    Like
    13
    0 Comments 0 Shares 5065 Views
  • The #HelloSoMee group is slowly growing and some pretty large stakes have joined. I appreciate those of you who have shown your commitment to help #SoMee grow by supporting #NewUsers as they join the site and introduce themselves. My plan is to open up the group to #Introductions and hosting a #HelloSoMeeBannerDesignContest when we have 100 members.

    As we get close to that number, I'll start posting some ideas for how to point new users towards the group, the best way to acknowledge them and ways to support them beyond the group. Thank you wieger for your efforts towards the same goal through the hashtag you've created. I'll be promoting the use of that as well.

    Please join the group with the intention of supporting new users as you see them in your Home Feed to help improve #UserRetention and help to build the #SoMeeCommunity. We need active users, not just new accounts.

    Here's the link;

    https://somee.social/groups/hellosomee

    ATTENTION::: If you are a new user, use the tag #NewOnSoMee for your first posts and you could earn some very sizeable votes.

    You can also Like the Awesme Tutorials page, which has a wealth of knowledge to help you on your SoMee journey
    https://somee.social/pages/AwesmeTutorials

    Note- The Hello SoMee group is solely for the use of new users to introduce themselves. All off topic posts will be deleted. Thank you

    #someeofficial #someeoriginals #originalcontent #introduction #introduceyourself #WelcomeToSoMee #UserRetention #SoMeeCommunity #BuildingCommunity #SoMeeContests #help #BeTheChange #WeAreAllInfluencers #decentralization
    The #HelloSoMee group is slowly growing and some pretty large stakes have joined. I appreciate those of you who have shown your commitment to help #SoMee grow by supporting #NewUsers as they join the site and introduce themselves. My plan is to open up the group to #Introductions and hosting a #HelloSoMeeBannerDesignContest when we have 100 members. As we get close to that number, I'll start posting some ideas for how to point new users towards the group, the best way to acknowledge them and ways to support them beyond the group. Thank you [wieger] for your efforts towards the same goal through the hashtag you've created. I'll be promoting the use of that as well. Please join the group with the intention of supporting new users as you see them in your Home Feed to help improve #UserRetention and help to build the #SoMeeCommunity. We need active users, not just new accounts. Here's the link; https://somee.social/groups/hellosomee ATTENTION::: If you are a new user, use the tag #NewOnSoMee for your first posts and you could earn some very sizeable votes. You can also Like the Awesme Tutorials page, which has a wealth of knowledge to help you on your SoMee journey https://somee.social/pages/AwesmeTutorials Note- The Hello SoMee group is solely for the use of new users to introduce themselves. All off topic posts will be deleted. Thank you #someeofficial #someeoriginals #originalcontent #introduction #introduceyourself #WelcomeToSoMee #UserRetention #SoMeeCommunity #BuildingCommunity #SoMeeContests #help #BeTheChange #WeAreAllInfluencers #decentralization
    SOMEE.SOCIAL
    Hello SoMee
    Please introduce yourself to the community. Sell yourself, rather than just giving us a short one-liner and add an image. A quality image improves the aesthetics of your content 1000%. Let us know how you found out about SoMee. Then tell us a little about yourself and the content you'll be...
    Like
    Love
    18
    0 Comments 0 Shares 20738 Views